Drug Interactions between cannabidiol and oxtriphylline
This report displays the potential drug interactions for the following 2 drugs:
- cannabidiol
- oxtriphylline
Interactions between your drugs
oxtriphylline cannabidiol
Applies to: oxtriphylline and cannabidiol
MONITOR: Concomitant use of cannabis (marijuana) may decrease the plasma concentrations of theophylline. Smoking marijuana has been reported to increase theophylline clearance, with effect similar to that of smoking tobacco. The mechanism of interaction has not been established, but may involve induction of CYP450 1A2-mediated metabolism by the cannabinoids in marijuana. In one study, theophylline clearance was increased by an average of 42% in chronic smokers of either marijuana or tobacco administered single oral doses of theophylline compared to nonsmokers of either substance. There was an additive increase in total clearance of approximately 79% in subjects who smoked both marijuana and tobacco compared to nonsmokers. It is not known whether, and to what extent, the interaction may occur with other routes of administration of cannabis or any of its cannabinoids. In vitro data suggest that delta-9-tetrahydrocannabinol may induce CYP450 1A2, while cannabidiol may induce or inhibit CYP450 1A2 at clinically relevant concentrations.
MANAGEMENT: Theophylline levels should be monitored closely in patients who use marijuana or its cannabinoids. Dosage adjustments may be required following initiation, discontinuation, or change of cannabis/cannabinoid use.
References (4)
- Jusko WJ, Schentag JJ, Clark JH, Gardner M, Yurchak AM (1978) "Enhanced biotransformation of theophylline in marijuana and tobacco smokers." Clin Pharmacol Ther, 24, p. 405-10
- Cerner Multum, Inc. "UK Summary of Product Characteristics."
- Cerner Multum, Inc. "Australian Product Information."
- (2017) "Product Information. Dronabinol (dronabinol)." Watson Pharmaceuticals
Drug and food interactions
cannabidiol food
Applies to: cannabidiol
ADJUST DOSING INTERVAL: Food may affect the plasma concentrations of cannabidiol. In healthy volunteers, administration of cannabidiol with a high-fat/high-calorie meal increased cannabidiol peak plasma concentration (Cmax) by 5-fold and systemic exposure (AUC) by 4-fold and reduced the total variability compared with administration in the fasted state.
GENERALLY AVOID: Grapefruit juice may increase the plasma concentrations of cannabidiol. The proposed mechanism is inhibition of CYP450 3A4-mediated metabolism of cannabidiol by certain compounds present in grapefruit. The interaction has not been studied, but the product labeling for cannabidiol recommends consideration of a dosage reduction when used with strong or moderate inhibitors of CYP450 3A4. In general, the effect of grapefruit juice is concentration-, dose- and preparation-dependent, and can vary widely among brands. Certain preparations of grapefruit juice (e.g., high dose, double strength) have sometimes demonstrated potent inhibition of CYP450 3A4, while other preparations (e.g., low dose, single strength) have typically demonstrated moderate inhibition.
MANAGEMENT: Cannabidiol should be taken about the same time each day consistently either with or without food. Patients should limit the consumption of grapefruit and grapefruit juice. If they are coadministered, cannabidiol levels should be monitored and the dosage adjusted as necessary.
References (1)
- (2018) "Product Information. Epidiolex (cannabidiol)." Greenwich Biosciences LLC
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
See also
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.